Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
Incisive Genetics
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Michael Hayden - Director at n-Lorem Foundation | The Org
Michael Hayden - Principal @ Chertoff Group - Recent News and Activity
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Michael Hayden Net Worth (2023) | wallmine
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
VIP Reception
Teva appoints genetics specialist as its first president of global R&D - PMLiVE
The Difficulties of Cloning a CEO - Bloomberg
Teva Goes High Tech to Deliver Medicine Through Implanted Microchip | Messianic Bible
Dr. Michael Hayden | OxfordBiomedica
DEF 14A
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Israel Ministry of Foreign Affairs - Premier Kathleen Wynne visited Teva Pharmaceutical Industries Ltd., where she met with Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer. Israeli Teva is
Michael R. Hayden - Wikipedia
Teva shares surge on corporate shake-up - MarketWatch
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture | Ctech
At Risk for Huntington's Disease: 'Darkness replaced by hope and light': taking stock of Huntington's disease research
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Meet the Investigator – HD Insights
